title: CCMCL1: a new model of aggressive mantle cell lymphoma.
authors.affiliation: Department of Laboratory Medicine, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH.
authors.forename: Xiaoxian
authors.initials: X
authors.lastname: Zhao
authors.affiliation: Department of Pathology and Laboratory Medicine, Sandra and Edward Meyer Cancer Center, Weill Cornell Medical College, New York, NY.
authors.forename: Selina
authors.initials: S
authors.lastname: Chen-Kiang
authors.affiliation: Department of Laboratory Medicine, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH.
authors.forename: Shashirekha
authors.initials: S
authors.lastname: Shetty
authors.affiliation: Department of Pathology and Laboratory Medicine, Sandra and Edward Meyer Cancer Center, Weill Cornell Medical College, New York, NY.
authors.forename: Maurizio
authors.initials: M
authors.lastname: Di Liberto
authors.affiliation: Department of Laboratory Medicine, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH.
authors.forename: Juraj
authors.initials: J
authors.lastname: Bodo
authors.affiliation: Department of Laboratory Medicine, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH.
authors.forename: Lisa
authors.initials: L
authors.lastname: Durkin
authors.affiliation: Department of Physiology and Biophysics, Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY.
authors.forename: Ken
authors.initials: K
authors.lastname: Eng
authors.affiliation: Department of Physiology and Biophysics, Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY.
authors.forename: Olivier
authors.initials: O
authors.lastname: Elemento
authors.affiliation: Department of Hematologic and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
authors.forename: Mitchell R
authors.initials: MR
authors.lastname: Smith
authors.affiliation: Department of Laboratory Medicine, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH.
authors.forename: Eric D
authors.initials: ED
authors.lastname: Hsi
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D000818:Animals; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001897:Boronic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D000069286:Bortezomib; D045744:Cell Line, Tumor; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy / Q000235:genetics / Q000473:pathology*; D008297:Male; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D008875:Middle Aged; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental; D010880:Piperidines; D011719:Pyrazines / Q000008:administration & dosage / Q000627:therapeutic use; D011720:Pyrazoles / Q000008:administration & dosage / Q000627:therapeutic use; D011743:Pyrimidines / Q000008:administration & dosage / Q000627:therapeutic use; D000069283:Rituximab; D014407:Tumor Cells, Cultured
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D001897:Boronic Acids; D010880:Piperidines; D011719:Pyrazines; D011720:Pyrazoles; D011743:Pyrimidines; C551803:ibrutinib; D000069283:Rituximab; D000069286:Bortezomib; D000225:Adenine